A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)
Clinical trial NCT06503731 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06503731
- Sponsor
- argenx
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-30
- Primary completion
- 2027-11-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.